|
National Health (Pharmaceutical Benefits) Regs (Am) |
|
|
National Health (Pharmaceutical Benefits) Regs (Am) |
The Legislative Instruments Database (LID) web site (decommissioned on April 1, 2008) has been replaced by the Federal Register of Legislative Instruments web site. Your browser should automatically take you there in 10 seconds. If it doesn't then please go to www.frli.gov.au.
__________
AND WHEREAS the Pharmaceutical Benefits Advisory Committee has recommended to the Minister that each of the following drugs or medicinal preparations be prescribed as a pharmaceutical benefit under section 85 of that Act, namely--
(a) ``INFASOY'';
(b) Nifedipine; and
(c) Ticarcillin Disodium:
AND WHEREAS it is desirable, amongst other things, to prescribe each of those drugs or medicinal preparations as a pharmaceutical benefit under that section:
NOW THEREFORE I, the Governor-General of the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953.
Dated 23 November 1982.
N. M. STEPHEN
Governor-General
By His Excellency's Command,
J. J. CARLTON
Minister of State for Health
__________
Commencement
1. These Regulations shall come into operation on 1 December 1982.
Schedule 1
2. Schedule 1 to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in Schedule 1.
Schedule 2
3. Schedule 2 to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in Schedule 2.
Schedule 3
4. Schedule 3 to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in Schedule 3.
Schedule 5
5. Schedule 5 to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in Schedule 4.
SCHEDULE 1 Regulation 2
AMENDMENTS OF SCHEDULE 1 TO THE NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS
1. After item 300 insert the following item:
"300A Dichlorphenamide Tablets".
2. After item 303 insert the following item:
"303A Dienoestrol Tablets".
3. After item 457 insert the following item:
"457A Glycerol Suppositories".
4. Omit item 651.
5. Omit item 670.
6. Omit item 1079.
__________
SCHEDULE 2 Regulation 3
AMENDMENTS OF SCHEDULE 2 TO THE NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS
1. Omit item 66.
2. Omit item 91.
3. Omit item 137, substitute the
following item:
"137 Hydrocortisone, B.P. Polymyxin B Sulphate, B.P.,
with Neomycin Sulphate, B.P.,
and Hydrocortisone, B.P.".
4. After item 146 insert the following
item:
"146A `INFASOY' --".
5. Omit item 147, substitute the
following item:
"147 Insulin Injection, Neutral, B.P. Insulin Injection, Isophane,
B.P., and Insulin Injection,
Neutral, B.P.".
6. Omit item 148, substitute the
following item:
"148 Insulin Injection, Isophane, B.P. Insulin Injection, Neutral,
B.P., and Insulin Injection,
Isophane, B.P.".
7. After item 167 insert the following
item:
"167A Metoclopramide Hydrochloride, --".
B.P.
8. Omit item 172, substitute the
following item:
"172 Natamycin --".
9. Omit item 173, substitute the
following item:
"173 Neomycin Sulphate, B.P. Bacitracin with Polymyxin B
Sulphate, B.P., and Neomycin
Sulphate, B.P. Colistin
Sulphate, B.P., with Neomycin
Sulphate, B.P. Gramicidin with
Nystatin, B.P., Triamcinolone
Acetonide, B.P., and Neomycin
Sulphate B.P. Hydrocortisone
Acetate, B.P., with Neomycin
Sulphate, B.P. Polymyxin B
Sulphate, B.P., with
Bacitracin Zinc, B.P., and
Neomycin Sulphate, B.P.
Polymyxin B Sulphate, B.P.,
with Gramicidin, and Neomycin
Sulphate, B.P. Polymyxin B
Sulphate, B.P., with
Hydrocortisone, B.P., and
Neomycin Sulphate, B.P.".
10. Omit item 219.
__________SCHEDULE 3 Regulation 4
AMENDMENTS OF SCHEDULE 3 TO THE NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS
1. Omit item 62.
2. Omit item 89.
3. After item 128 insert the following item:
"128A `INFASOY' ".
4. Omit item 136.
5. Omit item 137.
6. Omit item 138.
7. Omit item 139.
8. Omit item 140.
9. Omit item 141.
10. After item 180 insert the following item:
"180A Nifedipine".
11. Omit item 244.
12. After item 265 insert the following item:
"265A Ticarcillin Disodium".
__________SCHEDULE 4 Regulation 5
AMENDMENTS OF SCHEDULE 5 TO THE NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS
1. After item 5 insert the following
item:
"5A Amoxycillin Trihydrate, Infection of the lower urinary
B.P., Dispersible Tablets tract".
2. Omit item 6, substitute the
following item:
"6 Ascorbic Acid Tablets, B.P. Any disease or condition in a
pensioner or a dependant of a
pensioner".
3. Omit item 8, substitute the
following item:
"8 Azathioprine Tablets, B.P. With the written authority of the
Permanent Head-- Anaemia,
autoimmune haemolytic Continuing
azathioprine therapy initiated in a
hospital Dermatomyositis
Granulomatosis, Wegener's
Hepatitis, active, chronic Lupus
erythematosus, systemic Nephrotic
syndrome Organ transplant
Polyarteritis nodosa Pyoderma
gangrenosum Scleroderma
Thrombocytopenic purpura".
4. After item 10 insert the
following item:
"10A Beclomethasone With the written authority of the
Dipropionate, B.P., Capsules, 100 Permanent Head-- Chronic
micrograms intractable asthma requiring
maintenance corticosteroids in
children under the age of eight (8)
years who are unable to use a
metered aerosol spray".
5. Omit item 15, substitute the
following item:
"15 Bleomycin Sulphate Germ cell neoplasms Lymphoma
Squamous cell carcinoma".
6. Omit item 20, substitute the
following item:
"20 Calciferol Tablets, Hypoparathyroidism Osteomalacia
High-Strength, B.P. Hypocalcaemia following gastrectomy, severe
steatorrhoea or renal failure
Vitamin D-resistant rickets".
7. Omit item 21, substitute the
following item:
"21 Calcitriol With the written authority of the
Permanent Head-- Hypocalcaemia due
to renal disease
Hypoparathyroidism".
8. Omit item 24, substitute the
following items:
"24 Calcium Folinate, Injection Antidote to folic acid antagonists
"24A Calcium Folinate, Tablets, With the written authority of the
15 mg Permanent Head-- Antidote to folic
acid antagonists".
9. Omit item 34, substitute the
following item:
"34 Chlorambucil Tablets, B.P. With the written authority of the
Permanent Head-- Anaemia,
autoimmune, haemolytic Continuing
chlorambucil therapy initiated in a
hospital Granulomatosis, Wegener's
Leukaemia, chronic lymphatic Lupus
erythematosus, systemic Lymphoma
Myeloproliferative disorders
Polyarteritis nodosa Scleroderma
Thrombocytopenic purpura".
10. Omit item 47, substitute the
following item:
"47 Codeine Phosphate, B.P., Any disease or condition in a
with Aspirin, B.P., Soluble pensioner or a dependant of a
Tablets pensioner".
11. Omit item 48, substitute the
following item:
"48 Codeine Phosphate, B.P., With the written authority of the
with Aspirin, B.P., Tablets, Permanent Head-- Malignant
30mg-325mg neoplasia".
12. Omit item 49, substitute the
following item:
"49 Codeine Phosphate, B.P., Any disease or condition in a
with Paracetamol, B.P., Tablets, pensioner or a dependant of a
8mg-500mg pensioner".
13. Omit item 53, substitute the
following item:
"53 (1) Cyclophosphamide, B.P. With the written authority of the
(2) Cyclophosphamide Tablets, B.P. Permanent Head-- Anaemia,
autoimmune haemolytic Continuing
cyclophosphamide thereapy initiated
in a hospital Dermatomyositis
Granulomatosis, Wegener's
Hepatitis, active, chronic Lupus
erythematosus, systemic Malignant
disease including leukaemia
Nephritis Nephrotic syndrome
Polyarteritis nodosa Scleroderma
Thrombocytopenic purpura".
14. After item 55 insert the
following item:
"55A Daunorubicin With the written authority of the
Permanent Head-- Acute leukaemia".
15. Omit item 66.
16. After item 68 insert the
following item:
"68A Doxepin Hydrochloride, B.P. With the written authority of the
Tablet, 50mg (base) Permanent Head-- Endogenous
depression where there is an
inadequate response to not less
than 100mg of doxepin daily".
17. Omit item 72, substitute the
following item:
"72 Ergocalciferol, B.P. Hypocalcaemia Hypoparathyroidism
Osteomalacia following gastrectomy,
severe steatorrhoea or renal
failure Vitamin D-resistant
rickets".
18. Omit item 84, substitute the
following item:
"84 Glycerol, B.P., Suppositories Any disease or condition in a
paraplegic or quadriplegic patient
For use by patients who are
receiving long-term intensive
nursing care in hospitals or
nursing homes For use by patients
for whose care a Commonwealth
Domiciliary Nursing Care Benefit is
approved".
19. After item 89 insert the
following item:
"89A `INFASOY' With the written authority of the
Permanent Head-- Cows' milk allergy
in children under the age of two
(2) years Galactosaemia
Homocystinuria Lactose intolerance".
20. Omit item 91.
21. Omit item 95, substitute the
following item:
"95 Labetalol Hydrochloride Tablets Hyertension which fails to
respond adequately to multiple
antihypertensive drug therapy"
22. Omit item 100, substitute the
following item:
"100 (1) Medroxyprogesterone Breast cancer Endometrial cancer
Acetate, B.P., Injection,
50 mg Renal cell cancer".
in 1 ml (2) Medroxyprogesterone
Acetate B.P., Tablets
100 mg
23. Omit item 101, substitute the
following item:
"101 Medroxyprogesterone Breast cancer Endometrial cancer
Acetate, B.P., Injection, 150 mg Precocious puberty Renal cell
in 1 ml cancer".
24. Omit item 103, substitute the
following item:
"103 Medroxyprogesterone Breast cancer Dysfunctional uterine
Acetate, B.P., Tablets, 10 mg bleeding Endometrial cancer
Precocious puberty Renal cell
cancer Turner's syndrome".
25. Omit item 104.
26. Omit item 109, substitute the
following items:
"109 (1) Methotrexate, B.P., 5 With the written authority of the
mg Injection (2) Methotrexate Permanent Head-- Acute leukaemia
Injection, B.P., 5 mg (3) Breast cancer Chorioadenoma
Methotrexate Tablets, B.P. destruens Continuing methotrexate
therapy initiated in a hospital
Gestational choriocarcinoma Head
and neck epidermoid cell carcinoma
Hydatidiform mole Lung cancer
Lymphoma Osteogenic sarcoma Severe
intractable or extensive psoriasis
"109A (1) Methotrexate, B.P., 50 With the written authority of the
mg Injection (2) Methotrexate Permanent Head-- Head and neck
Injection, B.P., 50 mg epidermoid cell carcinoma Lymphoma
Osteogenic sarcoma".
27. After item 114 insert the
following item:
"114A Metoclopramide With the written authority of the
Hydrochloride, B.P. Permanent Head-- Gastric retention
after gastric surgery Malignant
neoplasia (late stage)".
28. Omit item 124, substitute the
following items:
"124 Nicotinic Acid Tablets, B.P. Any disease or condition in a
pensioner or a dependant of a
pensioner
"124A Nifedipine, Capsules, 10 mg With the written authority of the
Permanent Head-- Intractable angina
not responding to other therapy".
29. After item 133 insert the
following item:
"133A Papaveretum, Tablets 10 mg Disabling pain associated with
proven malignant neoplasia
Disabling pain of short duration
not responding to non-narcotic
analgesics, the maximum duration of
treatment being two weeks".
30. Omit item 134, substitute the
following item:
"134 (1) Penicillamine, B.P., With the written authority of the
(2) Penicillamine Capsules, B.P. Permanent Head-- Acute heavy metal
(3) Penicillamine Tablets, B.P. intoxication Cystinosis Cystinuria
with calculus formation For the
continuing treatment of rheumatoid
arthritis where penicillamine
therapy was initiated in a hospital
Haemoglobinuria, paroxysmal cold
Patients with rheumatoid arthritis
who are already receiving long-term
(greater than 6 months) therapy
with penicillamine Wilson's disease
(hepatolenticular degeneration)".
31. After item 153 insert the
following item:
"153A Procarbazine Hydrochloride With the written authority of the
Permanent Head-- Lymphoma Small
cell carcinoma of the lung".
32. Omit item 160, substitute the
following items:
"160 Riboflavine, B.P., Tablets Any disease or condition in a
pensioner or a dependant of a
pensioner
"160A Salbutamol Sulphate, B.P., With the written authority of the
Capsules, 200 micrograms Permanent Head-- Bronchial asthma
in children under the age of eight
(8) years who are unable to use a
metered aerosol spray".
33. Omit item 168.
34. Omit item 178, substitute the
following item:
"178 Thiamine Hydrochloride Any disease or condition in a
Tablets, B.P. pensioner or a dependant of a
pensioner".
35. Omit item 181, substitute the
following item:
"181 Ticarcillin Disodium With the written authority of the
Injection Permanent Head-- Infections where
positive bacteriological evidence
confirms that ticarcillin disodium
is the most appropriate therapeutic
agent Septicaemia, suspected or
proven".
36. After item 188 insert the
following item:
"188A Trimethoprim, B.P. Acute urinary tract infections".
NOTES
1. Notified in the Commonwealth of Australia Gazette on 30 November 1982.
2. Statutory Rules 1960 No. 17 as amended to date. For previous amendments see Note 2 to Statutory Rules 1982 No. 69 and see also Statutory Rules 1982 Nos. 69, 76 and 179.
The Legislative Instruments Database (LID) web site (decommissioned on April 1, 2008) has been replaced by the Federal Register of Legislative Instruments web site. Your browser should automatically take you there in 10 seconds. If it doesn't then please go to www.frli.gov.au.